U.S. stocks are ticking higher ahead of the Federal Reserve’s announcement coming later in the afternoon about what it will ...

Baird upgraded McKesson (NYSE:MCK) to outperform from neutral on Thursday, citing the updates the medical distributor gave ...

Drug distributor McKesson Corp raised its annual profit forecast on Wednesday, driven by increased sales in its U.S.

An arm of health care giant McKesson will pay $448,578 in back wages and interest as part of an agreement with the U.S.

McKesson Medical-Surgical Inc. entered into an agreement with the Labor Department on Monday resolving employment ...

The health care giant agreed to pay $448,000 in back wages to resolve hiring discrimination allegations at a DFW facility.

McKesson's earnings for its fiscal 2025 second quarter exceeded expectations, despite special charges that cut into net ...

McKesson (MCK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz ...

Shares of McKesson climbed after the drug distributor raised its fiscal-year guidance and reported strong sales growth during its fiscal second quarter. The stock was up 11%, at $610.99, in midday ...

Steve Baxter, an analyst from Wells Fargo, maintained the Hold rating on McKesson (MCK – Research Report). The associated price target ...

McKesson Corp (MCK) reports a 21% revenue increase and raises fiscal 2025 EPS guidance amid strategic expansions and ...